Bill > HR4623

This bill requires the Secretary of Health and Human Services to develop regulations mandating that direct-to-consumer television advertisements for prescription drugs and biological products (which are covered by Medicare or Medicaid) include a clear, truthful textual statement about the medication's list price. Specifically, the price would be based on the first day of the quarter when the ad is aired, and would represent the cost of a typical 30-day treatment or course of treatment. The bill gives the Administrator of the Centers for Medicare & Medicaid Services (CMS) discretion to determine several key details, including whether the pricing requirement should extend to other forms of advertising, the exact format of the price disclosure, appropriate enforcement mechanisms, and whether additional price information should be included. The regulations must be established within one year of the bill's enactment, with the goal of providing consumers with more transparent pricing information for prescription drugs and biological products when they see advertisements. The bill aims to help patients better understand the potential cost of medications they see advertised on television, including broadcast, cable, streaming, and satellite platforms.

Business and Industry

https://www.congress.gov/bill/119th-congress/house-bill/4623/all-info